)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Accelerate Diagnostics
Accelerate Diagnostics (AXDX) investor relations material
Accelerate Diagnostics has been delisted
Accelerate Diagnostics Q4 2024 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2024 earnings summary21 Mar, 2025
Executive summary
Q4 2024 net sales declined to $2.8M from $3.0M year-over-year, mainly due to lower consumable sales.
Full-year 2024 net sales were $11.7M, down from $12.1M in 2023, with a 3% increase in consumable product revenue offset by weak capital sales.
Q4 net loss was $9.6M ($0.38/share); full-year net loss was $50.0M ($2.15/share).
Company ended Q4 with $16.3M in cash and equivalents, down from $20.9M at the start of the quarter.
No plans for regular earnings calls; updates to be provided via SEC filings and investor relations materials.
Financial highlights
Q4 gross margin fell to 16% from 21% year-over-year due to higher manufacturing costs.
Full-year gross margin improved to 23% from 21% in 2023.
Q4 SG&A costs dropped to $4.6M from $5.8M; full-year SG&A was $21.3M, down from $31.2M.
Q4 R&D costs decreased to $3.8M from $5.6M; full-year R&D was $16.7M, down from $25.4M.
Adjusted loss from operations (excluding non-cash equity-based comp) was $6.97M in Q4 and $30.93M for the year.
Outlook and guidance
No explicit forward guidance provided; company will communicate future updates through SEC filings.
Management highlights ongoing commitment to timely financial disclosures.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Accelerate Diagnostics
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Accelerate Diagnostics Inc. is an in vitro diagnostics company specializing in rapid diagnostic solutions for infectious diseases. The company develops and markets systems and tests that enable the identification of pathogens and the determination of antimicrobial susceptibility directly from patient samples. Its flagship product, the Accelerate Pheno system, provides faster diagnostic results compared to traditional methods, helping healthcare providers optimize antimicrobial therapy and improve patient outcomes. The company is headquartered in Tucson, Arizona, and its shares are listed on the NASDAQ.